Picture this: Lawyers pouring over a decade of their lives into a colossal legal showdown, clocking in 375,000 hours and shelling out $100 million in costs, only to land a jaw-dropping $2.8 billion payout for their clients—but then feeling like they're still owed more. That's the gripping tale at the heart of the Blue Cross Blue Shield antitrust case, where class action attorneys are now fighting for a slice of future recoveries. But here's where it gets controversial—a move that's sparking heated debates about fairness in the legal world.
- Companies
November 12 (Reuters) - Thirteen years of intense legal battles, 375,000 hours of dedicated effort, and $100 million in out-of-pocket expenses. That's the staggering scale of work that plaintiffs' lawyers claim they invested in pursuing an antitrust class action lawsuit against the insurance giant Blue Cross Blue Shield, representing healthcare providers across the United States. Their perseverance paid dividends with a $2.8 billion settlement that wrapped up in August (https://www.reuters.com/legal/government/us-judge-approves-28-billion-blue-cross-settlement-with-health-providers-2025-08-19/), encompassing roughly $759 million for legal fees and expenses.
Sign up here. (https://www.reuters.com/legal/government/after-28-billion-settlement-class-lawyers-seek-share-next-blue-cross-cases-2025-11-12/undefined?location=article-paragraph&redirectUrl=%2Flegal%2Fgovernment%2Fafter-28-billion-settlement-class-lawyers-seek-share-next-blue-cross-cases-2025-11-12%2F)
For its part, Blue Cross has chosen not to comment and maintains that agreeing to the settlement doesn't imply any admission of wrongdoing.
While this represents a substantial reward for the plaintiffs' legal team, the lead class counsel—Joe Whatley and Edith Kallas from Whatley Kallas LLP—insist it's merely the tip of the iceberg in terms of their rightful compensation.
They're petitioning Chief U.S. District Judge R. David Proctor in Alabama to mandate that a percentage of upcoming settlements in connected lawsuits against Blue Cross—those handled by different attorneys—be set aside for them as extra payment. Their argument centers on the idea that their foundational efforts paved the way for these subsequent legal actions.
This dispute over fees isn't just a footnote in a lengthy antitrust drama; it underscores a persistent dilemma in large-scale litigation: When groundbreaking cases inspire additional lawsuits, how much recognition should the trailblazing attorneys receive? And this is the part most people miss—the tension often boils down to whether innovation in legal strategy deserves ongoing financial perks, or if it risks creating barriers for future claims.
In the past few months, lawyers from prominent firms have filed at least 20 fresh lawsuits against Blue Cross on behalf of healthcare providers who chose to opt out of the original class settlement (https://www.reuters.com/legal/government/hospitals-line-up-sue-blue-cross-opting-out-28-bln-settlement-2025-03-05/), including major players like Memorial Sloan-Kettering, Dignity Health, and Saint Luke’s Health System. These cases have been merged into multi-district litigation (https://www.jpml.uscourts.gov/sites/jpml/files/MDL-2406-Transfer_Order-7-25.pdf) in the Northern District of Alabama. Memorial Sloan-Kettering opted out of commenting, while Dignity Health and Saint Luke’s did not reply to inquiries.
Opting out remains a classic tactic in class action scenarios. The general belief is that participants can potentially secure larger individual payouts by retaining their own legal representation and pursuing separate claims, rather than settling for a portion of the collective settlement.
Whatley describes the opt-out claimants as engaging in 'free riding,' drawing a parallel to someone copying a classmate's assignment to achieve the same score without effort. 'The opt-out firms are essentially leveraging all our groundwork for their gain, and we haven't seen a single cent from it,' Whatley explained to me, referencing a precedent from the 11th U.S. Circuit Court of Appeals, which oversees Alabama, affirming that attorneys can be compensated for contributions that deliver a 'common benefit' to fellow litigants.
To set the stage, the lawsuit against Blue Cross began in 2012, when Whatley and fellow plaintiffs' attorneys filed suit on behalf of hospitals, doctors, and other healthcare professionals. They accused Blue Cross and certain affiliates of breaching antitrust laws by carving up the nation into territories and colluding to avoid competition, driving up insurance premiums and slashing reimbursement rates.
The matter reached a resolution after plaintiffs secured several pivotal court decisions, including the applicable antitrust review standard. Back in 2018, Judge Proctor ruled that the 'per se' standard applied, meaning Blue Cross's actions were automatically deemed anti-competitive, significantly boosting the plaintiffs' chances of success at trial.
Relying on these rulings and similar precedents, class counsel are advocating for 12.5% of any future recoveries from Blue Cross to be held in escrow as reimbursement for their extensive labor. The precise sum they'd collect would hinge on how much their prior contributions are judged to have aided the attorneys in the follow-up cases.
In response, the lawyers representing the opt-outs—from firms such as Paul Hastings, Duane Morris, McKool Smith, Zelle Law, and BRS LLP, none of whom provided comments—argue in court filings (https://tmsnrt.rs/3Xpv4wd) that class counsel are seeking extra funds 'for work they've already been fully paid for.' They contend that approving this would effectively place a claim on future proceeds, creating logistical headaches and hindering their ability to effectively argue their cases.
The opt-out attorneys have requested permission for discovery to verify class counsel's assertions that their earlier efforts would genuinely assist the new suits. They also challenge whether class counsel are overstating their influence, pointing to a parallel class action (https://www.reuters.com/legal/litigation/27-bln-blue-cross-antitrust-settlement-upheld-by-us-appeals-court-2023-10-25/) against Blue Cross focused on insurance policyholders (distinct from providers), led by other plaintiffs' lawyers tackling shared issues. That lawsuit concluded with a $2.7 billion settlement in 2022.
They emphasize that discovery is crucial 'to determine what specific work product can accurately be credited' to each legal team.
In their response filed on Friday (https://tmsnrt.rs/4ov4aPs), class counsel rejected the discovery request, labeling it as excessive and without precedent. 'The Providers acknowledge that the Opt-Outs will have significant tasks ahead to establish their damages,' wrote Whatley and Kallas. 'Nevertheless, they won't be beginning entirely from square one.'
This situation raises intriguing questions about the ethics of legal compensation in interconnected cases. Should attorneys who break new ground in landmark suits get a perpetual stake in similar future disputes, potentially discouraging innovation or creating unfair advantages? Or is it simply about rewarding foundational work that benefits the broader legal ecosystem? For instance, consider how this might mirror debates in other industries, like software patents where original inventors seek royalties on derivative technologies. It's a slippery slope—where do you draw the line between fair compensation and overreach?
What are your thoughts? Do you side with the pioneering class counsel, believing their groundwork entitles them to a share of future wins? Or do you agree with the opt-out lawyers that this could stifle individual litigation and complicate justice? Is there a middle ground, such as standardizing how 'common benefits' are valued across cases? We'd love to hear your opinions—agree, disagree, or offer a fresh perspective—in the comments below!
Reporting by Jenna Greene
Our Standards: The Thomson Reuters Trust Principles. (https://www.thomsonreuters.com/en/about-us/trust-principles.html)
Opinions expressed are those of the author. They do not reflect the views of Reuters News, which, under the Trust Principles, is committed to integrity, independence, and freedom from bias.
Jenna Greene covers legal business and culture, offering insights into professional trends, the people shaping cases, and unusual courtroom stories. With years of experience chronicling the legal field and high-stakes disputes, she resides in Northern California. Contact Greene at jenna.greene@thomsonreuters.com
